Shire Profit Triples on Sales of Vyvanse ADHD Drug (Update3)

Shire Profit Triples on Sales of Vyvanse ADHD Drug (Update3) - Bloomberg

Shire Profit Triples on Sales of Vyvanse ADHD Drug (Update3)
Bloomberg - 21 hours ago
Vyvanse contributed $65.9 million to sales, beating the analysts' estimate of $55 million. The company needs to reduce its reliance on hyperactivity drug …
Shire confident of approval for Vyvanse in adults Reuters
UPDATE 1-Shire 2007 earnings top forecast, upbeat on Vyvanse Reuters
Shire 2007 earnings top forecast, upbeat on Vyvanse Therapeutics Daily (subscription) (press release)
Forbes
all 30 news articles

February 22nd, 2008
Vyvanse

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner: